Healixia News - page 5

February 14, 2023

IFAPP Today newsletter - February 2023

Source: IFAPP

Please find here the link to the IFAPP TODAY newsletter of February 2023.

January 27, 2023

End of the validation procedure for SARS-CoV-2 antigen self-tests

The validation procedure for SARS-CoV-2 antigen self-tests with a CE-marking ceased to apply since 23 January 2023. The associated list of recommended SARS-CoV-2 antigen self-tests with a CE-marking is therefore no longer available.

Source: FAMHP

January 27, 2023

PRAC January 2023 - recommendations for Janus kinase (JAK) inhibitors and information about Zolgensma

Alignment of dose recommendations for Janus kinase (JAK) inhibitors in patients with certain risk factors
EMA’s safety committee (PRAC) has further reviewed measures to minimise the risk of serious side effects associated with Janus kinase (JAK) inhibitors used to treat several chronic inflammatory disorders.

Source: FAMHP

January 17, 2023

IFAPP Today newsletter - January 2023

Source: IFAPP

Please find here the link to the IFAPP TODAY newsletter of January 2023.

January 12, 2023

COVID-19: Audit Hospitals re-estimates hospital care not provided

Deze audit onderzoekt de niet-uitgevoerde ziekenhuiszorg en gecumuleerde potentiële zorgachterstanden vanaf het begin van de pandemie tot en met de zesde golf (van mei 2021 tot en met mei 2022).

L’audit porte sur les soins non effectués et les retards accumulés dans les hôpitaux depuis le début de la pandémie jusqu’à la sixième vague incluse (de mai 2021 à mai 2022).

Source: FAMHP

January 10, 2023

IFAPP virtual training workshop: Introduction to the new EU Clinical Trial Regulation

From 31 January 2023 all clinical trials with medicines must be authorised, handled and reported according to the rules lined out in the Regulation EU No 536/2014 (Clinical Trials Regulation).

January 10, 2023

Indexation of hospitality amounts, fees to apply for Mdeon visum and sponsoring virtual and hybrid meetings.

As from January 1st, 2023, a number of novelties will take effect regarding the amounts for hospitality, the amounts of the fees to apply for an Mdeon visum and the sponsoring of virtual and hybrid meetings.

January 10, 2023

Healixia Clinical Conference 2022: full report now available for download!

Our Clinical Conference on October 20^th 2022 was a success and we are happy to share a bit of it with you!

January 9, 2023

Belgium publishes the first report on antimicrobial resistance

Antimicrobiële resistentie, ook AMR genoemd, is één van de grootste bedreigingen voor de volksgezondheid. Daarom werd in samenwerking met verschillende Belgische autoriteiten een nationaal actieplan ontwikkeld. België publiceert het eerste “One Health”-rapport over AMR om de resultaten samen te vatten.

La résistance aux antimicrobiens, également appelée AMR, est l’une des principales menaces pour la santé publique. C’est pourquoi un plan national d’action a été développé en collaboration avec différentes autorités belges. La Belgique publie aujourd’hui son premier rapport « One Health » sur l’AMR pour synthétiser les résultats.

Source: FAMHP

December 23, 2022

Medical Affairs survey in collaboration with NVFG

Fill out the survey aims to map, for the first time in Benelux, the Medical Affairs professional and collect insight on demographics, role & responsibilities, education and other aspects. Target audience are Medical Advisors, Medical Science Liaisons and other Medical Affairs professionals; active in Benelux.